Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
ITF Therapeutics Launching A Study to Evaluate the Real-World Experience of Duvyzat (Givinostat) in Patients With Duchenne Muscular Dystrophy
Research
DMD Warrior
-
The purpose of this prospective observational study (NCT07127978) is to assess the safety, tolerability, and functional results of DMD...
Agamree to be sold in United Arab Emirates, Saudi Arabia, Kuwait, Oman and Bahrain starting in 2026
Press Releases
DMD Warrior
-
Santhera Pharmaceuticals announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE (vamorolone) in...
Santhera Secures Agreement with GEN for the Distribution of AGAMREE (Vamorolone) in Turkiye
Press Releases
DMD Warrior
-
Santhera Pharmaceuticals announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş....
Revidia Therapeutics MSI-1436 Holds Promise for Treating Heart Failure in DMD Patients
Research
DMD Warrior
-
Keros Therapeutics Focuses on Advancing KER-065 for Duchenne Muscular Dystrophy (DMD)
Press Releases
DMD Warrior
-
Preclinical Study: Cell Therapy Prevents Damage From Duchenne Muscular Dystrophy
Research
DMD Warrior
-
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)
Press Releases
DMD Warrior
-
Load more
